Situation Market shiftsince 04 Nov 2026
Active
Pharmaceutical MRP revisions and estimated savings reporting
Three linked items describe revised maximum retail prices (MRPs) announced by pharmaceutical companies for a set of drugs, together with estimated savings figures. One announcement covers 70 companies and 120 drugs; a report attaches an estimated saving of ₹3,357.49 crore to that same 70-company/120-drug figure; a third item reports 85 companies and 121 drugs with estimated savings of ₹3,541 crore. The cluster reflects price-revision reporting in the pharmaceutical market rather than a single named event.
3 members0 actorsrecorded 15 Nov 2026
Members
3Attached by part_of; a later discovery pass can detach a member.
EventAnnouncement
Completed
70 companies announced revised MRPs for 120 drugsEventReportCompleted
Estimated savings of ₹3,357.49 crore with 70 companies reporting revised MRPs for 120 drugsEventPrice revision reportingCompleted
85 companies report revised MRPs for 121 drugs, estimated savings ₹3,541 croreSource
No source quote is linked to this record.
Related situations
Same kind only, ranked by embedding similarity to this record.